The 11th annual National Alliance for Drug Endangered Children conference will provide training on the latest research and best practice strategies for drug endangered children efforts at the local, state, tribal and national levels. The conference will enable participants to enhance collaborative efforts to protect children from the harmful effects of their caregivers’ substance abuse. This conference is being held in in partnership with the Florida Alliance for Drug Endangered Children (Florida DEC).
Purpose:
The purpose of National DEC’s annual national conference is to raise awareness about the risks faced by drug endangered children and to provide information and training to practitioners from across the country on how to work collaboratively for better outcomes for these children. The annual conference promotes multidisciplinary collaborative advances in practice, research, and policy. The goal is to prevent child abuse and neglect by promoting more effective efforts to identify, rescue, and provide services for children and families affected by drug trafficking and substance use disorders.
Target Audience:
We anticipate nationwide representation of service providers and professionals, including child welfare providers, substance abuse treatment providers, juvenile and family court judges and attorneys, law enforcement, prosecutors, probation officers, prevention specialists, maternal and child health agencies, physicians, nurses, researchers and evaluators, educators, tribal communities, community organizations serving youth, and children and adult mental health providers.
Conference Objectives:
1. Describe chemical and environmental hazards surrounding illicit drug use and exposures.
2. State possible medical and psychological effects of illicit drug exposure.
3. Describe therapeutic management of drug affected children.
4. Discuss the need for care coordination among law enforcement, victim service providers, medical professionals, child welfare, and prosecutors to identify, protect, and provide victim services to drug endangered children.
5. Explain the roles and responsibilities of agencies, including the lead role of law enforcement and the importance of victim advocacy, to enhance collaboration.
6. Review interventions and treatments to support the family and provide care for child victims.
7. Discuss strategies to reduce neglect and abuse of drug endangered children and offer additional resources to professionals.
8. Review the impact of recovery on individuals, families, and communities.
Please check the box next to the following questions if the answer is 'yes'.
Conference funded by registration fees and the support of the Florida Alliance for Drug Endangered Children and their partners.
Florida Alliance for Drug Endangered Children (Florida DEC), Florida Attorney General Pam Bondi, the Florida Alcohol and Drug Abuse Association, and the Florida Department of Children and Families, Department of Law Enforcement, and Department of Health.
Please enter the applicable Event Date if there is an Event associated with this TTA.
When entering an Event Date, the Time is also required.
If the TTA is targeted to a particular audience or location, please complete the questions below.
Milestones are an element, activity, work product, or key task associated with completing the TTA (e.g. kick-off meeting, collect data from stake holders, deliver initial data analysis).
Please complete the fields below, if applicable, to create a milestone for this TTA.
Please respond to the Performance Metrics below. The Performance Metrics questions are based on the TTA Type indicated in the General Information section of the TTA.
Please submit a signed letter of support from your agency’s executive or other senior staff member. The letter can be emailed to or uploaded with this request. The letter should be submitted on official letterhead and include the following information:
- General information regarding the request for TTA services, i.e., the who, what, where, when, and why.
- The organizational and/or community needs specific to the request for TTA services.
- The benefits or anticipated outcomes from the receipt of TTA services.
By submitting this application to BJA NTTAC, I understand that upon approval of this application for TTA, the requestor agrees to keep BJA NTTAC informed of any circumstances that may impact the delivery of the TTA, including changes in the date of the event, event cancellation, or difficulties communicating with the assigned TTA provider.
Please call [site:phone] if you need further assistance completing this application.